1. Signaling Pathways
  2. Immunology/Inflammation
  3. Asialoglycoprotein Receptor (ASGPR)
  4. Asialoglycoprotein Receptor (ASGPR) Ligand

Asialoglycoprotein Receptor (ASGPR) Ligand

Asialoglycoprotein Receptor (ASGPR) Ligands (3):

Cat. No. Product Name Effect Purity
  • HY-171910
    tri(GalNAc-PEG2)-PEG4-cyclo(Ac-DCAW-{Arg(3F-Ph)-PEG2}-LGELVWCT) (Cys2-Cys12)
    Ligand 99.46%
    tri(GalNAc-PEG2)-PEG4-cyclo(Ac-DCAW-{Arg(3F-Ph)-PEG2}-LGELVWCT) (Cys2-Cys12) is an asialoglycoprotein receptor (ASGPR) ligand that can be used for LYsosome TArgeting Chimera (LYTAC) research.
  • HY-180909
    TMU454
    Ligand
    TMU454 is a prototype GalNAc-PROTAC conjugate. TMU454 binds to ASGPR on the membrane of cells, and then is internalized via ASGPR-mediated endocytosis. TMU454 selectively degrades BRD4. TMU454 exhibits anticancer activity against hepatocellular carcinoma.
  • HY-156994
    ASGPR ligand-1
    Ligand
    ASGPR ligand-1 (Compound int-CC2) is an asialoglycoprotein receptor (ASGPR) ligand with a binding Kd value of 0.9 nM. ASGPR ligand-1 is applicable to research on lysosome degradation-related diseases.